India Glycols Declares Interim Dividend of ₹7.50 per Share
India Glycols Limited has declared an interim dividend of ₹7.50 per equity share (150%) for FY 2025-26. The record date is March 23, 2026. Shareholders must submit tax documents by March 23, 2026. Dividends will be paid electronically.
An interim dividend directly benefits shareholders by providing them with a return on their investment. While positive, the impact is considered medium as it is a routine distribution of profits rather than a major strategic announcement.
The declaration of an interim dividend is a positive sign for shareholders, indicating the company's profitability and willingness to distribute profits.
India Glycols Limited announced the declaration of an interim dividend of ₹7.50 per equity share (150%) for the Financial Year 2025-26. The dividend is on shares with a face value of ₹5 each.
The record date for determining the eligibility of shareholders for this interim dividend has been fixed as Monday, March 23, 2026. The dividend will be paid to those shareholders whose names appear in the Register of Members of the Company or in the records of the Depositories as beneficial owners of the shares as on this record date.
The interim dividend will be paid within 30 days from the date of declaration. Shareholders are requested to submit their tax-related documents to the company at complianceofficer@indiaglycols.com and to its Registrar and Share Transfer Agent, MCS Share Transfer Agent Limited, at admin@mcsregistrars.com on or before March 23, 2026, to enable the company to determine the appropriate Tax Deduction at Source (TDS) rate. Dividend payments will be remitted only through electronic mode, and shareholders are advised to update their KYC (including bank details) with their respective Depository Participant or the Company's RTA to receive direct credit of dividends into their bank accounts. The dividend will be withheld for shareholders whose KYC is not completed.
This information is also available on the Investor Relations section of the company's website (www.indiaglycols.com) and on the websites of BSE Limited (www.bseindia.com) and the National Stock Exchange of India Limited (www.nseindia.com).
What to do with a filing like this
India Glycols Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by India Glycols Limited. Read the original for the full detail.